Welcome to CDC stacks | The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates - 32326 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates
Filetype[PDF-38.66 KB]


No Related Documents.
You May Also Like:
  1. in economic evaluations of genetic testing
    Personal Author:
    Grosse, Scott D.; Khoury, Muin J.;
    Published:
    Sep 08 2016
    Source:
    Genet Med. 18(10):963-965
    File Type:
    Filetype[PDF - 39.43 KB]
  2. When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
    Personal Author:
    Grosse, Scott D.
    Published:
    2015
    Source:
    Healthcare (Basel). 3(4):860-878.
    Description:
    Varying estimates of the cost-effectiveness of genomic testing applications can reflect differences in study questions, settings, methods and assumptions. This review compares recently published cost-effectiveness analyses of testing strategies for L...
    File Type:
    Filetype[PDF - 231.06 KB]
  3. Coming Soon
    depends!
    Personal Author:
    Grosse, Scott D.
    Published:
    May 15 2018
    Source:
    Genet Med. 21(1):252-253
    Public Access
    Available on:
    April 01, 2019
  4. Coming Soon
    Clinical penetrance in hereditary hemochromatosis: estimates of the cumulative incidence of severe liver disease among HFE C282Y homozygotes
    Personal Author:
    Grosse, Scott D.; Gurrin, Lyle C.; Bertalli, Nadine A.; Allen, Katrina J.;
    Published:
    Aug 03 2017
    Source:
    Genet Med. 20(4):383-389.
    Description:
    Iron overload (hemochromatosis) can cause serious, symptomatic disease that is preventable if detected early and managed appropriately. The leading cause of hemochromatosis in populations of predominantly European ancestry is homozygosity of the C282...
    Public Access
    Available on:
    April 01, 2019
  5. Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility
    Personal Author:
    Grosse, Scott D.
    Published:
    Oct 10 2013
    Source:
    Genet Med. 16(3):225-227.
    File Type:
    Filetype[PDF - 53.77 KB]